Canada markets open in 9 hours 11 minutes

CG Oncology, Inc. (CGON)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
30.02-2.41 (-7.43%)
At close: 04:00PM EDT
30.94 +0.92 (+3.06%)
After hours: 07:08PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.16B
Enterprise Value 2.28B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)688.49
Price/Book (mrq)N/A
Enterprise Value/Revenue 11.18k
Enterprise Value/EBITDA -41.16

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-19.24%
S&P500 52-Week Change 326.43%
52 Week High 350.23
52 Week Low 328.55
50-Day Moving Average 338.65
200-Day Moving Average 339.56

Share Statistics

Avg Vol (3 month) 3605.45k
Avg Vol (10 day) 3921.32k
Shares Outstanding 566.64M
Implied Shares Outstanding 671.99M
Float 843.68M
% Held by Insiders 17.05%
% Held by Institutions 145.68%
Shares Short (Apr 15, 2024) 42.8M
Short Ratio (Apr 15, 2024) 44.25
Short % of Float (Apr 15, 2024) 44.25%
Short % of Shares Outstanding (Apr 15, 2024) 44.20%
Shares Short (prior month Mar 15, 2024) 41.99M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,893,200.00%

Management Effectiveness

Return on Assets (ttm)-19.97%
Return on Equity (ttm)-31.36%

Income Statement

Revenue (ttm)204k
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -55.43M
Net Income Avi to Common (ttm)-67.8M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)187.67M
Total Cash Per Share (mrq)2.82
Total Debt (mrq)461k
Total Debt/Equity (mrq)0.25%
Current Ratio (mrq)13.62
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-45.68M
Levered Free Cash Flow (ttm)-28.07M